Use of a multi-gene pharmacogenetic panel reduces adverse drug effects

Cell Rep Med. 2023 May 16;4(5):101021. doi: 10.1016/j.xcrm.2023.101021. Epub 2023 Apr 20.


Swen et al.1 examine the utility of multi-gene pharmacogenetic testing in a large multi-national cohort. They show fewer adverse drug reactions among patients receiving testing and prescribing recommendations based on genotype results compared with those receiving usual care.

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Drug-Related Side Effects and Adverse Reactions* / genetics
  • Drug-Related Side Effects and Adverse Reactions* / prevention & control
  • Genotype
  • Humans
  • Pharmacogenetics* / methods
  • Pharmacogenomic Testing / methods